Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

ANVISARegulator guidanceAnalytical method validationMedicinesHigh confidenceLast verified October 13, 2026

RDC 166/2017

Validation of analytical methods

Current edition

RDC 166 of July 24, 2017 (in force)

About this standard

Criteria for validating analytical methods used on pharmaceutical ingredients, medicines and biological products in all production phases.

Recognition by market

Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts

No market listing is published yet.

Testing requirements that cite it

Open the market page and its pathway pages for the full requirement, protocol and report content

Related standards: FDA analytical procedures guidance, Q2(R2), USP <1224>, USP <1225>, USP <1226>, USP <621>, Q14, M10, ASEAN analytical validation guideline, Taiwan analytical validation manual. See all standards.

Not legal or regulatory advice. Check the current official rules before you act. Parts of the approvals data are official open data reused under open licences. Data sources.

LinkedInLinkedInXXYouTubeYouTube